Biology Reference
In-Depth Information
24. Bermpohl D, You Z, Lo EH, Kim H-H, Whalen MJ. TNF alpha and Fas mediate tissue
damage and functional outcome after traumatic brain injury in mice. J Cereb Blood Flow
Metab 2007;27(11):1806-18.
25. Ertel W, Keel M, Stocker R, Imhof HG, Leist M, Steckholzer U, et al. Detectable con-
centrations of Fas ligand in cerebrospinal fluid after severe head injury. J Neuroimmunol
1997;80(1-2):93-96.
26. Lenzlinger PM, Marx A, Trentz O, Kossmann T, Morganti-Kossmann MC. Prolonged
intrathecal release of soluble Fas following severe traumatic brain injury in humans.
J Neuroimmunol 2002;122(1-2):167-74.
27. Clark RS, Kochanek PM, Adelson PD, Bell MJ, Carcillo JA, Chen M, et al. Increases in
Bcl-2 protein in cerebrospinal fluid and evidence for programmed cell death in infants and
children after severe traumatic brain injury. J Pediatr 2000;137(2):197-204.
28. Clark RS, Kochanek PM, Chen M, Watkins SC, Marion DW, Chen J, et al. Increases in
Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J
1999;13(8):813-21.
29. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas
ligand, a novel member of the tumor necrosis factor family. Cell 1993;75(6):1169-78.
30. Nagata S, Golstein P. The Fas death factor. Science 1995;267(5203):1449-56.
31. Park DR, Thomsen AR, Frevert CW, Pham U, Skerrett SJ, Kiener PA, et al. Fas (CD95)
induces proinflammatory cytokine responses by human monocytes and monocyte-derived
macrophages. J Immunol 2003;170(12):6209-16.
32. Choi C, Park JY, Lee J, Lim JH, Shin EC, Ahn YS, et al. Fas ligand and Fas are expressed
constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-
alpha, or IFN-gamma. J Immunol 1999;162(4):1889-95.
33. Clark RS, Schiding JK, Kaczorowski SL, Marion DW, Kochanek PM. Neutrophil accu-
mulation after traumatic brain injury in rats: comparison of weight drop and controlled
cortical impact models. J Neurotrauma 1994;11(5):499-506.
34. Whalen MJ, Carlos TM, Kochanek PM, Clark RS, Heineman S, Schiding JK, et al.
Neutrophils do not mediate blood-brain barrier permeability early after controlled cortical
impact in rats. J Neurotrauma 1999;16(7):583-94.
35. Uhl MW, Biagas KV, Grundl PD, Barmada MA, Schiding JK, Nemoto EM, et al. Effects
of neutropenia on edema, histology, and cerebral blood flow after traumatic brain injury in
rats. J Neurotrauma 1994;11(3):303-15.
36. Whalen MJ, Carlos TM, Wisniewski SR, Clark RS, Mellick JA, Marion DW, et al. Effect
of neutropenia and granulocyte colony stimulating factor-induced neutrophilia on blood-
brain barrier permeability and brain edema after traumatic brain injury in rats. Crit Care
Med 2000;28(11):3710-17.
37. Pleines UE, Stover JF, Kossmann T, Trentz O, Morganti-Kossmann MC. Soluble ICAM-1
in CSF coincides with the extent of cerebral damage in patients with severe traumatic
brain injury. J Neurotrauma 1998;15(6):399-409.
38. Whalen MJ, Carlos TM, Dixon CE, Schiding JK, Clark RS, Baum E, et al. Effect of trau-
matic brain injury in mice deficient in intercellular adhesion molecule-1: assessment of
histopathologic and functional outcome. J Neurotrauma 1999;16(4):299-309.
39. Otto V, Heinzel-Pleines U, Gloor S, Trentz O, Kossmann T, Morganti-Kossmann M.
sICAM-1 and TNF- induce MIP-2 with distinct kinetics in astrocytes and brain micro-
vascular endothelial cells. J Neurosci Res 2000;60:733-42.
40. Rancan M, Otto VI, Hans VHJ, Gerlach I, Jork R, Trentz O, et al. Upregulation of
ICAM-1 and MCP-1 but not of MIP-2 and sensorimotor deficit in response to traumatic
axonal injury in rats. J Neurosci Res 2001;63:438-46.
